©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2941-2951
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2941
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2941
Effectiveness and safety of sequential transarterial chemoembolization and microwave ablation for subphrenic hepatocellular carcinoma: A comprehensive evaluation
Zi-Yi Zhu, Zhen Qian, Zhong-Qiang Qin, Bo Xie, Jian-Zhu Wei, Pei-Pei Yang, Mu Yuan, Department of Interventional Radiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, Anhui Province, China
Author contributions: Yuan M contributed to the conception and design; Qian Z, Qin ZQ, Xie B, Wei JZ, and Yang PP are responsible for the provision of the study materials and data collection; Zhu ZY and Yuan M contributed to the data analysis and interpretation; Zhu ZY contributed to the manuscript writing; All authors read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by The First Affiliated Hospital of Bengbu Medical University (Approval No. 2024KY047).
Informed consent statement: Informed consent was waived by the First Affiliated Hospital of Bengbu Medical University Institutional Review Board.
Conflict-of-interest statement: All the authors report having no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
Corresponding author: Mu Yuan, MD, Associate Chief Physician, Department of Interventional Radiology, The First Affiliated Hospital of Bengbu Medical University, No. 287 Changhuai Road, Longzihu District, Bengbu 233004, Anhui Province, China. yuanmu2008@163.com
Received: January 1, 2024
Revised: April 11, 2024
Accepted: May 27, 2024
Published online: July 15, 2024
Processing time: 193 Days and 6.2 Hours
Revised: April 11, 2024
Accepted: May 27, 2024
Published online: July 15, 2024
Processing time: 193 Days and 6.2 Hours
Core Tip
Core Tip: Tumors located under the diaphragm present a challenge when it comes to percutaneous thermal ablation of liver tumors, as they have a higher likelihood of recurrence compared to resection and laparoscopic ablation. There is a solution that can enhance the accuracy of localization and increase the coverage of ablation: the combination of transarterial chemoembolization and percutaneous thermal ablation. In addition, the concurrent application of multiple antennas to create a confluent ablation zone has been successfully employed in recent years. Thus, we aim to investigate the effectiveness and safety of the combination therapy for tumors located under the diaphragm.